| Code | Description | Claims | Beneficiaries | Total Paid |
| 36415 |
Collection of venous blood by venipuncture |
47,939 |
35,599 |
$4.13M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,067 |
29,635 |
$1.15M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,667 |
7,404 |
$1.01M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,316 |
7,126 |
$732K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,038 |
6,726 |
$575K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,754 |
9,690 |
$451K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,412 |
2,212 |
$446K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,913 |
4,593 |
$371K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,517 |
10,246 |
$340K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,267 |
4,435 |
$308K |
| 81025 |
|
11,087 |
10,228 |
$308K |
| 81001 |
|
18,163 |
16,361 |
$307K |
| 80053 |
Comprehensive metabolic panel |
24,213 |
21,074 |
$306K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,674 |
1,926 |
$292K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,456 |
3,211 |
$248K |
| 82565 |
|
735 |
671 |
$180K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
869 |
844 |
$175K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,374 |
5,679 |
$162K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
202 |
199 |
$161K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,696 |
8,921 |
$158K |
| 86850 |
|
2,602 |
2,389 |
$139K |
| 71046 |
Radiologic examination, chest; 2 views |
6,850 |
6,506 |
$137K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,446 |
17,059 |
$133K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,561 |
12,537 |
$129K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,900 |
1,728 |
$129K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
931 |
883 |
$127K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,246 |
1,192 |
$125K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,632 |
4,319 |
$125K |
| 87081 |
|
3,446 |
3,368 |
$120K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,784 |
1,728 |
$118K |
| 73130 |
|
1,235 |
1,191 |
$116K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,302 |
2,204 |
$99K |
| 76830 |
Ultrasound, transvaginal |
678 |
660 |
$95K |
| 81003 |
|
4,963 |
4,661 |
$94K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,940 |
4,690 |
$91K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,389 |
16,407 |
$89K |
| 73110 |
|
989 |
957 |
$87K |
| 73610 |
|
1,694 |
1,638 |
$84K |
| 87077 |
|
4,182 |
3,985 |
$83K |
| 73630 |
|
1,732 |
1,657 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,442 |
1,603 |
$78K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,945 |
12,662 |
$76K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,928 |
1,843 |
$71K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,212 |
2,127 |
$65K |
| 71045 |
Radiologic examination, chest; single view |
8,719 |
7,810 |
$65K |
| 76801 |
|
602 |
528 |
$65K |
| 87210 |
|
1,642 |
1,547 |
$62K |
| 87070 |
|
1,654 |
1,587 |
$54K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,109 |
1,088 |
$53K |
| 71250 |
|
268 |
263 |
$52K |
| 73030 |
|
1,172 |
1,109 |
$49K |
| 93971 |
|
375 |
365 |
$45K |
| 80047 |
|
2,022 |
1,944 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,178 |
30,437 |
$34K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,484 |
1,455 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,941 |
1,870 |
$33K |
| 12001 |
|
297 |
293 |
$31K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
590 |
564 |
$27K |
| 96376 |
|
4,460 |
2,800 |
$27K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,360 |
1,256 |
$27K |
| G0378 |
Hospital observation service, per hour |
5,389 |
4,304 |
$26K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
153 |
145 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,371 |
7,615 |
$25K |
| 72100 |
|
800 |
787 |
$24K |
| 73564 |
|
654 |
623 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,851 |
1,684 |
$21K |
| 73090 |
|
244 |
235 |
$21K |
| 93017 |
|
436 |
420 |
$21K |
| 59025 |
Fetal non-stress test |
427 |
268 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,979 |
1,694 |
$18K |
| 74018 |
|
537 |
499 |
$16K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
555 |
553 |
$15K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
29 |
29 |
$15K |
| 84112 |
|
56 |
52 |
$15K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
891 |
865 |
$13K |
| 88304 |
|
294 |
292 |
$12K |
| 73080 |
|
167 |
165 |
$12K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,648 |
6,860 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
944 |
871 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
669 |
500 |
$11K |
| 80061 |
Lipid panel |
3,535 |
3,413 |
$11K |
| 73502 |
|
542 |
499 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,254 |
7,582 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,158 |
2,108 |
$9K |
| 82950 |
|
920 |
884 |
$9K |
| 80076 |
|
3,211 |
2,931 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,893 |
5,669 |
$8K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
43 |
42 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,699 |
2,968 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,223 |
3,034 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
848 |
799 |
$7K |
| 81511 |
|
13 |
12 |
$6K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,069 |
1,694 |
$6K |
| 76770 |
|
114 |
112 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,011 |
11,042 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,251 |
1,308 |
$6K |
| 73560 |
|
135 |
130 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
56 |
56 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,063 |
2,884 |
$5K |
| 87807 |
|
393 |
387 |
$5K |
| 84702 |
|
2,928 |
2,469 |
$4K |
| 93225 |
|
13 |
13 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,238 |
1,180 |
$4K |
| 93970 |
|
24 |
24 |
$4K |
| J3490 |
Unclassified drugs |
5,693 |
3,753 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
540 |
533 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,154 |
9,452 |
$3K |
| 97161 |
|
1,036 |
951 |
$3K |
| 82247 |
|
420 |
243 |
$3K |
| 84484 |
|
8,468 |
6,661 |
$3K |
| 85027 |
|
4,643 |
4,129 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
399 |
346 |
$3K |
| 73140 |
|
41 |
40 |
$3K |
| 93976 |
|
1,385 |
1,288 |
$3K |
| 82962 |
|
29 |
22 |
$3K |
| 76642 |
|
77 |
66 |
$3K |
| 86900 |
|
3,036 |
2,780 |
$3K |
| 70496 |
|
30 |
29 |
$3K |
| 83735 |
|
7,790 |
5,576 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,096 |
2,337 |
$2K |
| 85007 |
|
803 |
687 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
2,202 |
757 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
92 |
80 |
$2K |
| 72040 |
|
37 |
36 |
$2K |
| 12002 |
|
26 |
26 |
$2K |
| 82570 |
|
986 |
835 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
161 |
160 |
$2K |
| 97165 |
|
170 |
158 |
$2K |
| 84439 |
|
1,274 |
1,226 |
$2K |
| 83880 |
|
2,631 |
2,322 |
$2K |
| 86803 |
|
1,555 |
1,499 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
16 |
15 |
$2K |
| 86780 |
|
910 |
851 |
$2K |
| 86762 |
|
1,009 |
919 |
$2K |
| 92523 |
|
12 |
12 |
$2K |
| 82105 |
|
29 |
29 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,342 |
2,721 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,069 |
409 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
921 |
860 |
$1K |
| 86140 |
|
2,543 |
2,268 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,254 |
1,228 |
$1K |
| 73660 |
|
12 |
12 |
$1K |
| 85610 |
|
3,638 |
3,183 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,763 |
2,604 |
$1K |
| 82803 |
|
1,019 |
890 |
$1K |
| 12011 |
|
15 |
15 |
$1K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$1K |
| 97116 |
|
414 |
207 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,510 |
5,183 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
40 |
38 |
$1K |
| 82140 |
|
31 |
28 |
$1K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,115 |
944 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,220 |
3,359 |
$997.58 |
| 70498 |
|
41 |
40 |
$951.78 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,199 |
1,016 |
$887.25 |
| 93922 |
|
13 |
12 |
$884.51 |
| 87040 |
|
2,513 |
2,224 |
$833.22 |
| 76775 |
|
24 |
24 |
$783.47 |
| 86901 |
|
3,037 |
2,781 |
$773.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,805 |
7,829 |
$766.80 |
| J1790 |
Injection, droperidol, up to 5 mg |
106 |
97 |
$764.44 |
| 97535 |
Self-care/home management training, each 15 minutes |
453 |
252 |
$743.96 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
869 |
617 |
$738.47 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,253 |
3,072 |
$725.02 |
| 80143 |
|
914 |
853 |
$685.83 |
| 87045 |
|
29 |
27 |
$653.39 |
| A4300 |
Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access |
12 |
12 |
$536.44 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
27 |
25 |
$495.56 |
| 82607 |
|
309 |
303 |
$458.00 |
| 86592 |
|
365 |
327 |
$455.55 |
| 90715 |
|
687 |
678 |
$442.11 |
| 83540 |
|
142 |
140 |
$435.85 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
483 |
461 |
$419.67 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
59 |
53 |
$396.86 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
179 |
86 |
$363.82 |
| J3480 |
Injection, potassium chloride, per 2 meq |
195 |
132 |
$363.45 |
| J1940 |
Injection, furosemide, up to 20 mg |
49 |
25 |
$356.46 |
| 90686 |
|
30 |
26 |
$356.46 |
| 97162 |
|
26 |
26 |
$353.55 |
| 73590 |
|
27 |
26 |
$289.18 |
| 82150 |
|
161 |
158 |
$253.17 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,835 |
1,761 |
$230.08 |
| 82728 |
|
176 |
162 |
$228.60 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
4,796 |
3,745 |
$215.30 |
| 85379 |
|
2,373 |
2,215 |
$183.38 |
| 82947 |
|
119 |
118 |
$166.21 |
| 87340 |
|
1,174 |
1,079 |
$159.27 |
| 86787 |
|
987 |
911 |
$158.66 |
| 83690 |
|
9,590 |
8,515 |
$157.62 |
| 83605 |
|
3,499 |
3,054 |
$148.76 |
| 82550 |
|
1,500 |
1,326 |
$128.14 |
| 84156 |
|
544 |
451 |
$106.80 |
| 82077 |
|
1,746 |
1,584 |
$103.81 |
| 62323 |
|
41 |
38 |
$99.40 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
789 |
547 |
$94.29 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
12 |
$91.45 |
| 87186 |
|
3,063 |
2,924 |
$64.19 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
24 |
18 |
$50.21 |
| 84550 |
|
422 |
348 |
$49.48 |
| 85730 |
|
2,387 |
2,081 |
$40.13 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,657 |
2,218 |
$38.38 |
| 85014 |
|
2,081 |
1,952 |
$30.97 |
| 84145 |
|
750 |
665 |
$28.76 |
| 80179 |
|
742 |
698 |
$23.49 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
354 |
329 |
$23.33 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,175 |
2,999 |
$20.41 |
| 83655 |
|
14 |
13 |
$15.61 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
503 |
458 |
$14.39 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
601 |
578 |
$10.10 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,302 |
1,189 |
$6.32 |
| 85652 |
|
925 |
862 |
$4.90 |
| 85651 |
|
993 |
886 |
$3.65 |
| 85018 |
|
292 |
222 |
$2.49 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,108 |
1,513 |
$1.51 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
432 |
386 |
$1.20 |
| J2060 |
Injection, lorazepam, 2 mg |
560 |
469 |
$0.35 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,009 |
814 |
$0.00 |
| 82248 |
|
471 |
281 |
$0.00 |
| 84100 |
|
428 |
352 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
95 |
67 |
$0.00 |
| 96367 |
|
408 |
317 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
78 |
77 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
61 |
60 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
197 |
185 |
$0.00 |
| 97168 |
|
154 |
148 |
$0.00 |
| 76942 |
|
84 |
82 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
44 |
31 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
84 |
60 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
29 |
29 |
$0.00 |
| 87075 |
|
41 |
38 |
$0.00 |
| 84466 |
|
38 |
38 |
$0.00 |
| 86336 |
|
16 |
16 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
42 |
41 |
$0.00 |
| 76000 |
|
26 |
26 |
$0.00 |
| 93308 |
|
29 |
26 |
$0.00 |
| 51701 |
|
59 |
55 |
$0.00 |
| 82010 |
|
42 |
38 |
$0.00 |
| 86308 |
|
103 |
101 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
780 |
650 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
85 |
81 |
$0.00 |
| 83615 |
|
294 |
240 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
82 |
68 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
65 |
64 |
$0.00 |
| 86580 |
|
33 |
26 |
$0.00 |
| 87205 |
|
291 |
269 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
28 |
24 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
30 |
27 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$0.00 |
| 82677 |
|
16 |
16 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
152 |
129 |
$0.00 |
| 82746 |
|
52 |
52 |
$0.00 |
| 88300 |
|
12 |
12 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
25 |
25 |
$0.00 |